Loading company…
Riskpilot
← Back to search
Sign in
Get full access
K/S DANISH BIOVENTURE
K/S
Active
CVR 32277047
Axeltorv 2
Ikke-finansielle holdingselskaber · NACE 642020
Est. 2009
— employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2021
DKK -33K
+80% vs 2020
EBITDA margin
100.0%
-80% vs 2020
Equity ratio
31.7%
Financial strength
Net profit 2021
DKK 513K
+2037% vs 2020
EBITDA — year on year
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2017
0M
0%
2018
0M
0%
2019
0M
0%
2020
0M
0%
2021
Key figures
Annual report 2021
Revenue
DKK -33K
+80%
EBITDA
DKK -33K
-80%
Net profit
DKK 513K
+2037%
Total assets
DKK 1,2M
-69%
Equity
DKK 366K
-90%
Employees
—
—
Company information
Legal name
K/S DANISH BIOVENTURE
CVR number
32277047
Legal form
Kommanditselskab
NACE code
642020 · Ikke-finansielle holdingselskaber
Founded
30. juni 2009
Share capital
—
Employees
—
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Contact
Address
Axeltorv 2
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Ikke-finansielle holdingselskaber
Companies in København
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2017
0M
2018
0M
2019
0M
2020
0M
2021
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2017
0M
2018
0M
2019
0M
2020
0M
2021
Income statement
DKK thousands
Item
2017
2018
2019
2020
2021
Revenue
-14
-30
-27
-18
-33
Staff expenses
-0
-0
-0
-0
-0
EBITDA
-14
-30
-27
-18
-33
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
-14
-30
-27
-18
-33
Net financials
25.616
20
0
-8
546
Profit before tax
25.603
-10
-27
-26
513
Tax
-0
-0
-0
-0
-0
Net profit
25.603
-10
-27
-26
513
Balance sheet
DKK thousands
Item
2017
2018
2019
2020
2021
Total assets
3.958
3.949
3.654
3.676
1.155
Equity
3.940
3.930
3.634
3.659
366
Long-term debt
0
0
0
0
0
Short-term debt
18
19
20
18
790
Total debt
18
19
20
18
790
Financial ratios
5-year trend
EBITDA margin
-3293200.0%
This company
15.8%
Market median
-20843138% vs market
2017
2021
Equity ratio
31.7%
This company
38.2%
Market median
+17% vs market
2017
2021
Return on equity
140.3%
This company
18.4%
Market median
+663% vs market
2017
2021
Net profit margin
51291900.0%
This company
8.1%
Market median
+633233233% vs market
2017
2021
Asset turnover
-0.03×
This company
1.12×
Market median
-103% vs market
2017
2021
Debt / equity
2.16×
This company
0.62×
Market median
-248% vs market
2017
2021
Annual reports & filings
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
View
PDF
Annual report 2018
Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
View
PDF
Annual report 2017
Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Former (1)
SF
Søren Fogh
Unofficial title
Unofficial title
2022 – 2023
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of K/S DANISH BIOVENTURE also hold positions in
0
other companies.
Person
Role here
Other companies
Søren Fogh
Unofficial title
0 companies